rs786204061
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PM4
The NM_000546.6(TP53):c.831_848dupTCCTGGGAGAGACCGGCG(p.Arg283_Thr284insProGlyArgAspArgArg) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000546.6 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Li-Fraumeni syndrome Uncertain:1
In summary, this is a novel, in-frame duplication with uncertain impact on protein function. While this region of TP53 is important for DNA binding, the evidence is insufficient at this time to prove that this sequence change affects protein function or causes disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change inserts 18 nucleotides in exon 8 of the TP53 mRNA (c.831_848dupTCCTGGGAGAGACCGGCG). This leads to the insertion of 6 amino acid residues in the TP53 protein (p.Pro278_Arg283dup), but otherwise preserves the integrity of the reading frame. This sequence change has not been published in the literature and is not present in population databases. The 6 duplicated amino acid residues Pro278-Arg283 fall in the DNA binding domain of the TP53 protein (amino acids 102-292) (PMID: 8276238). Several missense substitutions at these six codons have been reported in affected patients (PMID: 10864200, 11370630, 15173255, 8688334) and have been shown experimentally to disrupt TP53 protein function (PMID: 17606709, 21343334). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at